1. Durvalumab (Imfinzi) associated with risk of myasthenia gravis

   News item 09 May 2020 Pages: 1 - 1

2. Evaluation of potential therapies for COVID-19 global pandemic

   News item 09 May 2020 Pages: 2 - 2

3. Irish prescribers reminded of hepatotoxicity with paracetamol

   News item 09 May 2020 Pages: 3 - 3

4. Low-dose cannabidiol has acceptability safety profile

   News item 09 May 2020 Pages: 4 - 4

5. Rivaroxaban contraindicated in patients with prosthetic heart valves

   News item 09 May 2020 Pages: 5 - 5

6. UMC: use appropriate COVID-19-related terms for ICSRs

   News item 09 May 2020 Pages: 6 - 6

7. Antipsychotics increase risk of acute respiratory failure

   Clinical study 09 May 2020 Pages: 7 - 7

8. Clinical simulations cost effective in reducing medication errors

   Clinical study 09 May 2020 Pages: 8 - 8

9. Demand for potentially hazardous COVID-19 treatments

   Clinical study 09 May 2020 Pages: 9 - 9

10. Hydroxychloroquine-associated QT interval prolongation

    Clinical study 09 May 2020 Pages: 10 - 10

11. Systematic review: ADHD medications in pregnancy

    Clinical study 09 May 2020 Pages: 11 - 11

12. Verapamil or diltiazem: adverse bleeding events with concurrent DOACs

    Clinical study 09 May 2020 Pages: 12 - 12

13. Other adverse reaction research

    News item 09 May 2020 Pages: 13 - 13

14. Abacavir

    Case report 09 May 2020 Pages: 14 - 14

15. Abemaciclib/fulvestrant

    Case report 09 May 2020 Pages: 15 - 15

16. Adalimumab

    Case report 09 May 2020 Pages: 16 - 16

17. Adalimumab/etanercept/infliximab

    Case report 09 May 2020 Pages: 17 - 17

18. Afatinib/erlotinib/gefitinib/osimertinib

    Case report 09 May 2020 Pages: 18 - 18

19. Alemtuzumab

    Case report 09 May 2020 Pages: 19 - 19

20. Alemtuzumab

    Case report 09 May 2020 Pages: 20 - 20

21. Alteplase

    Case report 09 May 2020 Pages: 21 - 21

22. Amantadine/levodopa/rotigotine

    Case report 09 May 2020 Pages: 22 - 22

23. Amiodarone

    Case report 09 May 2020 Pages: 23 - 23

24. Amiodarone/loperamide/magnesium

    Case report 09 May 2020 Pages: 24 - 24

25. Amoxicillin/clavulanic-acid

    Case report 09 May 2020 Pages: 25 - 25

26. Amphotericin B liposomal

    Case report 09 May 2020 Pages: 26 - 26

27. Anlotinib/gefitinib

    Case report 09 May 2020 Pages: 27 - 27

28. Antibacterials

    Case report 09 May 2020 Pages: 28 - 28

29. Antibacterials/antiretrovirals

    Case report 09 May 2020 Pages: 29 - 29

30. Antidepressants/atenolol/hydroxyzine

    Case report 09 May 2020 Pages: 30 - 30

31. Antiepileptic-drugs

    Case report 09 May 2020 Pages: 31 - 31

32. Antiepileptics/Cefepime

    Case report 09 May 2020 Pages: 32 - 32

33. Antihyperglycaemics

    Case report 09 May 2020 Pages: 33 - 33

34. Antineoplastics

    Case report 09 May 2020 Pages: 34 - 34

35. Antineoplastics

    Case report 09 May 2020 Pages: 35 - 35

36. Antineoplastics

    Case report 09 May 2020 Pages: 36 - 36

37. Antineoplastics

    Case report 09 May 2020 Pages: 37 - 37

38. Antineoplastics

    Case report 09 May 2020 Pages: 38 - 38

39. Antineoplastics

    Case report 09 May 2020 Pages: 39 - 39

40. Antineoplastics

    Case report 09 May 2020 Pages: 40 - 40

41. Antineoplastics

    Case report 09 May 2020 Pages: 41 - 41

42. Antipsychotics

    Case report 09 May 2020 Pages: 42 - 42

43. Antiretrovirals

    Case report 09 May 2020 Pages: 43 - 43

44. Antithymocyte globulin/mycophenolate/tacrolimus

    Case report 09 May 2020 Pages: 44 - 44

45. Antituberculars

    Case report 09 May 2020 Pages: 45 - 45

46. Antivirals

    Case report 09 May 2020 Pages: 46 - 46

47. Antivirals/immunosuppressants

    Case report 09 May 2020 Pages: 47 - 47

48. Apixaban

    Case report 09 May 2020 Pages: 48 - 48

49. Apixaban/aspirin/thienopyridines

    Case report 09 May 2020 Pages: 49 - 49

50. Arginine/lutetium-(177lu)-oxodotreotide/lysine-hydrochloride

    Case report 09 May 2020 Pages: 50 - 50